Search Within

Gastrointestinal Oncology Service

Formats
  1. Journal Article (2351)
  2. Meeting Abstract (1873)
  3. Review (150)
  4. Book Section (127)
  5. Editorial (101)
  6. Guidelines (40)
  7. Correspondence (34)
  8. Conference Paper (24)
  9. Miscellaneous (23)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Solid Tumor Oncology Division (4752)
  2. Department of Medicine (4750)
  3. Center for Pancreatic Cancer Research (2317)
  4. Surgery (1067)
  5. Survivorship Research (1014)
  6. Epidemiology and Biostatistics (844)

More Groups

People
  1. Eileen O'Reilly (805)
  2. Leonard Saltz (796)
  3. Ghassan Abou-Alfa (583)
  4. Nancy Kemeny (545)
  5. David Kelsen (538)
  6. David Ilson (443)

More People

Years
  1. 2025 (227)
  2. 2024 (309)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1290)
  2. Annals of Oncology (331)
  3. Annals of Surgical Oncology (148)
  4. Cancer (128)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1379)
  2. Oxford University Press (462)
  3. Elsevier Inc. (408)
  4. Springer (322)
  5. American Association for Cancer Research (282)
  6. Wiley Blackwell (243)

More Publishers

Results (4752)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Loss of human epidermal growth factor receptor 2 (HER2) expression in HER2-overexpressing esophagogastric (EG) tumors treated with trastuzumab
    Meeting Abstract

    Janjigian, Y. Y.; Riches, J. C.; Ku, G. Y.; Imtiaz, T.; Capanu, M.; Chou, J. F.; Kelsen, D. P.; Ilson, D. H.; Berger, M. F.; Vakiani, E.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase II study of afatinib in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab refractory esophagogastric (EG) cancer
    Meeting Abstract

    Janjigian, Y. Y.; Ku, G. Y.; Ilson, D. H.; Boyar, M. S.; Capanu, M.; Chou, J. F.; Kelsen, D. P.; Imtiaz, T.; Berger, M. F.; Vakiani, E.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Intensity-modulated radiation therapy (IMRT) in patients with locally advanced pancreatic cancer (LAPC)
    Meeting Abstract

    Hajj, C.; Huguet, F.; Wu, A. J. C.; O'Reilly, E. M.; Winston, C.; Reidy, D. L.; Allen, P. J.; Goodman, K. A.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Overall survival and clinical characteristics in BRCA mutation carriers with stage I/II pancreatic cancer (PC)
    Meeting Abstract

    Golan, T.; Sella, T.; Javle, M. M.; Borgida, A.; O'Reilly, E. M.; Kelsen, D. P.; Epelbaum, R.; Kindler, H. L.; Katz, M. H. G.; Gallinger, S.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Effect of coadministration of propranolol and etodolac (VT-122) plus sorafenib for patients with advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    de la Torre, A. N.; Castaneda, I.; Hezel, A. F.; Bascomb, N. F.; Bhattacharyya, G. S.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Coagulation factors in citrated plasma predict for benefit from bevacizumab (B) in patients with advanced pancreatic cancer (APC): Results from CALGB 80303 (Alliance)
    Meeting Abstract

    Clarke, J. M.; Pang, H.; Starr, M. D.; Hatch, A. J.; Kindler, H. L.; O'Reilly, E. M.; Innocenti, F.; Venook, A. P.; Hurwitz, H.; Nixon, A. B.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Comprehensive multiplatform biomarker analysis of 313 hepatocellular carcinoma to identify potential therapeutic options
    Meeting Abstract

    Abou-Alfa, G. K.; Miura, J. T.; Gamblin, T. C.; Xiu, J.; Millis, S. Z.; Gatalica, Z.; Reddy, S. K.; Ang, C.; Yee, N. S.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • The DASH Study: A phase 1b study of dalantercept plus sorafenib in advanced hepatocellular carcinoma
    Meeting Abstract

    Abou-Alfa, G. K.; Miksad, R. A.; Gutierrez, M.; Tejani, M. A.; Sharma, M.; Sun, W. J.; Henderson, C. A.; Baron, A. D.; Olowokure, O. O.; Pearsall, R. S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase 3 randomized, double-blind, controlled study of cabozantinib (XL184) versus placebo in subjects with hepatocellular carcinoma who have received prior sorafenib (CELESTIAL; NCT01908426)
    Meeting Abstract

    Abou-Alfa, G. K.; Cheng, A. L.; Meyer, T.; El-Khoueiry, A. B.; Ikeda, M.; Chun, H. G.; Furuse, J.; Knox, J. J.; Okusaka, T.; Ping, J.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Older people with access to hand-held devices: Who are they?
    Journal Article

    Shahrokni, A.; Mahmoudzadeh, S.; Saeedi, R.; Ghasemzadeh, H.
    Telemedicine and e-Health (2015)

    Fulltext@MSK | Save